8-K: Universal Health Services Reports Q2 2026 Results, Revises Forecast

Universal Health Services, Inc. announced its second quarter 2026 financial results, reporting increased net income and revenues, and provided a revised full-year operating forecast.

Summary

• For the second quarter of 2026, Universal Health Services (UHS) reported net income of $358.4 million, or $5.98 per diluted share, compared to $353.2 million, or $5.43 per diluted share, in the second quarter of 2025.
• Net revenues for Q2 2026 increased by 8.3% to $4.638 billion, up from $4.284 billion in Q2 2025.
• The company reported EBITDA net of NCI of $680.2 million for Q2 2026, an increase from $651.4 million in Q2 2025.
• Adjusted EBITDA net of NCI was $677.9 million for Q2 2026, up from $642.9 million in Q2 2025.
• For the first six months of 2026, net income attributable to UHS was $707.1 million, or $11.63 per diluted share, compared to $669.9 million, or $10.23 per diluted share, in the same period of 2025.
• Net revenues for the first six months of 2026 increased by 8.9% to $9.133 billion, up from $8.384 billion in the comparable period of 2025.
• UHS is revising its full-year 2026 operating results forecast, with the midpoint of the revised net revenue forecast representing a 0.2% increase and the midpoint of the revised Adjusted EBITDA net of NCI forecast representing a 1.9% decrease compared to the original forecast.
• The company expects to spend approximately $950 million to $1.1 billion on capital expenditures in 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive report. While revenue growth is positive, the downward revision to the full-year profit forecast tempers enthusiasm. The company is managing operational challenges and leveraging specific programs, but future profitability guidance has been adjusted.

Positives

• Second quarter net income increased to $358.4 million from $353.2 million year-over-year.
• Second quarter net revenues grew by 8.3% to $4.638 billion.
• EBITDA net of NCI increased to $680.2 million in Q2 2026 from $651.4 million in Q2 2025.
• Adjusted EBITDA net of NCI increased to $677.9 million in Q2 2026 from $642.9 million in Q2 2025.
• Six-month net income increased to $707.1 million from $669.9 million year-over-year.
• Six-month net revenues increased by 8.9% to $9.133 billion.
• Acute care services on a same-facility basis saw net revenue increase by 8.2% in Q2 2026.
• Behavioral health care services on a same-facility basis saw net revenue increase by 7.4% in Q2 2026.

Negatives

• The midpoint of the revised 2026 Adjusted EBITDA net of NCI forecast represents a 1.9% decrease compared to the midpoint of the original forecast.
• The midpoint of the revised 2026 Adjusted EPS-diluted forecast represents a 2.6% decrease compared to the original forecast.
• Net cash provided by operating activities decreased by $64 million to $845 million for the six-month period ended June 30, 2026, compared to $909 million in the prior year period.
• There was an unfavorable change of $207 million in other working capital accounts due primarily to the timing of accounts payable disbursements.
• There was an unfavorable change of $45 million in accounts receivable.

Risks

• Changes to federal and state government programs like Medicare and Medicaid could materially affect program payments and impact results.
• Failure to renew supplemental Medicaid payment programs or qualify for future funds could materially impact results.
• Legislation limiting Medicaid enrollment and expenditures, and placing limits on provider fees, may reduce revenues and increase uncompensated care.
• Increased interest rates have significantly increased interest expense, reducing free cash flow.
• The outcome of known and unknown litigation, liabilities, and other claims could have a material adverse effect on the company.
• The ability to successfully complete and integrate the proposed acquisition of Talkspace, Inc. and realize expected benefits and synergies.

Future Outlook

The company is revising its full-year 2026 operating results forecast. The midpoint of the revised net revenue forecast is $18.6315 billion (a 0.2% increase from the original midpoint), the midpoint of the revised Adjusted EBITDA net of NCI forecast is $2.6635 billion (a 1.9% decrease from the original midpoint), and the midpoint of the revised Adjusted EPS-diluted forecast is $22.965 per share (a 2.6% decrease from the original midpoint). Capital expenditures for 2026 are expected to be between $950 million and $1.1 billion.

Management Comments

• The company announced financial results for the three and six-month periods ended June 30, 2026, and revised its 2026 full-year operating results forecast.
• The Q2 2026 results included a favorable net pre-tax impact of approximately $72 million, primarily from a Florida Medicaid directed payment program, partially offset by an increase in the reserve for self-insured claims.
• The Q2 2025 results included aggregate net pre-tax incremental reimbursements of approximately $101 million from Medicaid programs and a pre-tax loss of $25 million from a newly constructed hospital.

Industry Context

StockSavvy.ai notes that Universal Health Services' results reflect continued revenue growth in both acute care and behavioral health segments, a positive trend in the healthcare services industry. However, the downward revision in the EBITDA and EPS forecast, despite revenue increases, suggests potential margin pressures or increased operating costs impacting profitability.

Comparison to Industry Standards

• No direct comparisons to specific global benchmarks or named competitors were provided in the filing.
• The filing focuses on internal performance metrics and year-over-year comparisons.

Legal Proceedings

• The filing references potential material adverse effects from the outcome of known and unknown litigation, liabilities, and other claims, specifically mentioning matters related to Cumberland Hospital for Children and Adolescents.

Stakeholder Impact

• Shareholders: The revised forecast for Adjusted EBITDA and Adjusted EPS may impact share price expectations. Stock repurchase program continues, returning capital to shareholders.
• Creditors: The company has significant available borrowing capacity and is amending its credit agreement, indicating ongoing access to capital markets.
• Suppliers: No specific impact mentioned.
• Employees: No specific impact mentioned.
• Customers: Continued focus on delivering patient outcomes and contributing to health and wellbeing.

Next Steps

• The company will hold a conference call for investors and analysts on July 28, 2026.
• The acquisition of Talkspace, Inc. is expected to be finalized during the third quarter of 2026.
• The company may elect to utilize the new $700 million delayed draw term loan A by September 30, 2026.

Key Dates

Recommendation

The company demonstrates consistent revenue growth and operational stability, particularly in its core segments. However, the downward revision to the full-year profit forecast, coupled with ongoing risks related to government program changes and litigation, warrants a cautious approach. The potential capital raises and acquisition integration also introduce near-term uncertainty. Therefore, a 'hold' recommendation is appropriate pending clearer visibility on margin improvement and successful integration.

Keywords

healthcare services, hospital operations, behavioral health, acute care, Medicaid, Medicare, financial results, EBITDA